Answers are grounded in this paper and cite their sources.
Investigates arginine vasopressin's role in glymphatic flow in the hippocampus, suggesting implications for neurodegenerative conditions.
This study investigates whether arginine vasopressin modulates glymphatic flow in a circadian-dependent manner and restores flow after circadian disruption in the hippocampus. Using Glymph-FIT, a novel model for slow-flow DCE-MRI, we also assess the effects of AVP and V1A receptor antagonist Relcovaptan on glymphatic dynamics.
No takes yet. Share an insight, caveat, or question.
Hamed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: